<DOC>
	<DOCNO>NCT00636987</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety effectiveness Biocor Biocor Supra Valves .</brief_summary>
	<brief_title>Aortic Mitral Valve Replacement With Biocor Biocor Supra</brief_title>
	<detailed_description>The clinical investigation multi-center , prospective , non-randomized , observational , FDA-required post-approval study design evaluate safety effectiveness Biocor Biocor Supra Valves .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Stenosis</mesh_term>
	<criteria>Requires aortic mitral valve replacement ( heart surgery bypass allow time ) Legal age Signed informed consent prior surgery Willing complete followup requirement Pregnant nursing woman Already valve replace scheduled replacement Needs another valve replace Can return require followup visit Have active endocarditis Acute preoperative neurological event ( stroke ) Renal dialysis History substance abuse within one year prison inmate Participating another study Had Biocor Biocor Supra valve implant device explanted Life expectancy less five year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>aortic valve</keyword>
	<keyword>mitral valve</keyword>
	<keyword>heart valve</keyword>
	<keyword>tissue valve</keyword>
	<keyword>bioprosthesis</keyword>
	<keyword>valve disorder</keyword>
	<keyword>valve disease</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>aortic valve regurgitation</keyword>
	<keyword>aortic valve stenosis</keyword>
	<keyword>mitral valve regurgitation</keyword>
	<keyword>mitral valve stenosis</keyword>
</DOC>